Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Odanacatib in men with osteoporosis
2010-019454-41Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in osteoporosis comparing Odanacatib with Placebo (2 arms). Primary endpoint: Percent change from baseline in lumbar spine bone mineral density at Month 24. Started Jun 2010; status: completed.
02
Drugs
odanacatib
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2010-019454-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019454-41.